< Back to previous page
Researcher
Agnieszka Wozniak
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Jul 2006 → 30 Sep 2022
Projects
1 - 9 of 9
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Chicken chorioallantoic membrane (CAM) model as a research tool complementary to patient-derived xenografts (PDX) for preclinical drug testing in sarcomas.From1 Oct 2022 → TodayFunding: BOF - projects
- Preclinical evaluation of innovative cytotoxic drugs for the treatment of soft tissue sarcomaFrom28 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the biology of translocation-related sarcomas and impact on the research for new therapy options.From1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- CYTOTOXIC THERAPY REVISED: EXPLORATION OF INNOVATIVE (PRO)DRUGS IN PATIENT-DERIVED XENOGRAFTS OF SOFT TISSUE SARCOMAFrom1 Sep 2018 → 25 Oct 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of soft tissue sarcoma and the potential clinical applicationsFrom26 Sep 2017 → 25 Feb 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical outcome, Pathological results and immunohistochemical findings of rare subtypes of soft tissue sarcomasFrom10 Aug 2015 → 30 Sep 2017Funding: Nonprofit institution or equivalents
- Establishment of new research models and in vivo efficacy testing of novel treatment strategies for resistant gastrointestinal stromal tumorsFrom1 Aug 2014 → 19 May 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting soft tissue sarcoma with smart molecules - exploring cytotoxic prodrugs and target-specific inhibitors in patient-derived xenograftsFrom1 Aug 2013 → 30 Nov 2017Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 107
- Current role of topoisomerase I inhibitors for the treatment of mesenchymal malignancies and their potential future use as payload of sarcoma-specific antibody-drug conjugates(2024)
Authors: Patrick Schöffski, Agnieszka Wozniak
- A multiplatform metabolomics approach for comprehensive analysis of GIST xenografts with various KIT mutations(2023)
Authors: Agnieszka Wozniak, Patrick Schöffski
Pages: 3883 - 3891 - Antitumor Efficacy of the Novel KIT Inhibitor IDRX-42 (Formerly M4205) in Patient- and Cell Line-Derived Xenograft Models of Gastrointestinal Stromal Tumor (GIST)(2023)
Authors: Luna De Sutter, Agnieszka Wozniak, Lore De Cock, Raf Sciot, Patrick Schöffski
Pages: 2859 - 2868 - Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.(2023)
Authors: Agnieszka Wozniak, Patrick Schöffski
Pages: 1941 - 1954 - Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice.(2023)
Authors: Diether Lambrechts, Bram Boeckx, Agnieszka Wozniak, Patrick Schöffski
Pages: 101632 - Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice(2023)
Authors: Diether Lambrechts, Bram Boeckx, Agnieszka Wozniak, Patrick Schöffski
- The urokinase plasminogen activator receptor-associated protein (uPARAP) is an attractive target for the development of antibody-drug conjugates (ADCs) for treatment of mesenchymal malignancies(2023)
Authors: Agnieszka Wozniak, Patrick Schöffski
- Organoids developed from synovial sarcoma patient-derived xenografts(2023)
Authors: Agnieszka Wozniak, Patrick Schöffski
- Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)(2022)
Authors: Agnieszka Wozniak, Patrick Schöffski
- Machine learning for rhabdomyosarcoma histopathology(2022)
Authors: Agnieszka Wozniak, Patrick Schöffski
Pages: 1193 - 1203